Home Cart Sign in  
Chemical Structure| 147366-41-4 Chemical Structure| 147366-41-4

Structure of MKT-077
CAS No.: 147366-41-4

Chemical Structure| 147366-41-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MKT-077 (FJ-776) is a water-soluble rhodacyanine dye with antitumor activity. It can bind to Hsp70 family member mortalin-2 and inhibit its interactions with p53.

Synonyms: FJ-776

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MKT-077

CAS No. :147366-41-4
Formula : C21H22ClN3OS2
M.W : 432.00
SMILES Code : O=C1N(CC)/C(S/C1=C2SC3=CC=CC=C3N\2C)=C/C4=CC=CC=[N+]4CC.[Cl-]
Synonyms :
FJ-776
MDL No. :MFCD00953420

Safety of MKT-077

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of MKT-077

DNA

Isoform Comparison

Biological Activity

Description
MKT-077 (FJ-776), a highly water-soluble mitochondrial dye, demonstrates significant antitumor activity[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF-7/TAM-R 0.1–100 µM 48 h To evaluate the cytotoxicity of MKT-077 in breast cancer cells and its synergy with tamoxifen. PMC10895875
T47D/TAM-R 0.1–100 µM 48 h To evaluate the cytotoxicity of MKT-077 in breast cancer cells and its synergy with tamoxifen. PMC10895875
Huh7.5 cells 0.5, 1, and 5 µM 48 h MKT077 significantly reduced the production of infectious ZIKV particles, with a 3-log reduction in viral titre for pre-treatment and a 4-log reduction for post-treatment samples. PMC6455116
HeLa cells 0.35-1.2 μM 24 h MKT-077 promotes the clearance of hyperphosphorylated tau in a dose-dependent manner. PMC3146629
leukemic clam hemocytes (LCH) 1 to 7 μM 6 to 8 h disruption of mortalin/p53 binding and translocation of some p53 to the nuclei of cells treated with MKT-077 PMC1606587
A375 cells 10 μM 24 h Evaluate the effect of MKT-077 on apoptosis and autophagy. Results showed that MKT-077 significantly inhibited autophagy, evidenced by SQSTM1 accumulation and increased LC3 II levels. PMC3928135
H1299 cells 10 μM 24 h Evaluate the effect of MKT-077 on apoptosis and autophagy. Results showed that MKT-077 significantly inhibited autophagy, evidenced by SQSTM1 accumulation and increased LC3 II levels. PMC3928135
MZ-CRC-1 cells 0.1 to 10 μM 48 h MKT-077 suppressed MZ-CRC-1 cell viability at higher doses with an IC50 of 11.4 μM, primarily inducing cell cycle arrest rather than cell death PMC4722416
TT cells 0.1 to 10 μM 48 h MKT-077 significantly reduced TT cell viability with an IC50 of 0.74 μM, inducing cell cycle arrest and cell death PMC4722416

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice TT cell xenograft model Intraperitoneal injection 10 mg/kg Every 2 days, total 10 doses MKT-077 significantly suppressed the growth of TT xenografts, reducing tumor weight by approximately two-fold PMC4722416

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.31mL

0.46mL

0.23mL

11.57mL

2.31mL

1.16mL

23.15mL

4.63mL

2.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories